glp 1 stock market GLP-1 Agonists Report 2025-2033, By Product, Molecule, and Geo Novo Nordisk to cut 9,000

All of us produce GLP-1, which is an incretin hormone that gets released into our bloodstream when we eat

A 2022 study published in Diabetes, Obesity and Metabolism found that adults over 50 achieved clinically significant weight loss on semaglutide, with cardiovascular and metabolic risk reductions comparable to younger cohorts, though the authors noted the importance of individualized monitoring protocols for older patients given the higher baseline prevalence of comorbidities

L., John, L

GLP-1 treatments like Wegovy, Zepbound, Mounjaro, and compounded Semaglutide and Tirzepatide are helping people see real, lasting weight loss results, often without the need for surgery